[go: up one dir, main page]

ES8502992A1 - PROCEDURE FOR THE PREPARATION OF A (TIO) -ETER OF 2-METHYL-LISERG-8-ILO - Google Patents

PROCEDURE FOR THE PREPARATION OF A (TIO) -ETER OF 2-METHYL-LISERG-8-ILO

Info

Publication number
ES8502992A1
ES8502992A1 ES524815A ES524815A ES8502992A1 ES 8502992 A1 ES8502992 A1 ES 8502992A1 ES 524815 A ES524815 A ES 524815A ES 524815 A ES524815 A ES 524815A ES 8502992 A1 ES8502992 A1 ES 8502992A1
Authority
ES
Spain
Prior art keywords
alkyl
ilo
tio
formula
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524815A
Other languages
Spanish (es)
Other versions
ES524815A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8502992A1 publication Critical patent/ES8502992A1/en
Publication of ES524815A0 publication Critical patent/ES524815A0/en
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN (TIO)-ETER DE 2-METIL-LISERG-8-ILO.COMPRENDE REEMPLAZAR EL GRUPO Y EN UN DERIVADO 8-CH2Y CORRESPONDIENTE EN EL QUE Y ES UN GRUPO SUSCEPTIBLE DE SER ELIMINADO, TAL COMO UN COMPUESTO DE FORMULA (II), POR UN RADICAL ETER O TIOETER, TAL COMO UN GRUPO DE FORMULA (III) Y RECUPERAR EL COMPUESTO DE FORMULA (I) EN FORMA DE UNA SAL DE ADICION DEL MISMO, EN LA QUE X SIQNIFICA O O S; R1 SIGNIFICA H, ALQUILO C 1 A 4 O FENILO; R2 SIGNIFICA ALQUILO C 1 A 3 Y R3 SIGNIFICA FENILO O PIRIDILO, SIS SUSTITUIR O LLEVANDO CADA UNO, UNO, DOS O TRES SUSTITUYENTES ELEGIDOS ENTRE UN NUMERO ATOMICO DE 9 A 35, ALQUILO C 1 A 4 Y ALCOXI C 1 A 4, O REPRESENTA ALQUILO C 1 A 4 Y SALES DE ADICION DE ACIDOS DE LOS COMPUESTOS. LA REACCION SE REALIZA A TEMPERATURA ENTRE 50 Y 100JC Y EN UNA ATMOSFERA DE UN GAS INERTE COMO NITROGENO.PROCEDURE FOR THE PREPARATION OF A (TIO)-ETHER OF 2-METHYL-LYSERG-8-ILO. INCLUDES REPLACING THE GROUP AND IN A CORRESPONDING 8-CH2Y DERIVATIVE IN WHICH AND IS A GROUP LIKELY TO BE ELIMINATED, SUCH AS A COMPOUND OF FORMULA (II), BY AN ETHER OR TIOETHER RADICAL, SUCH AS A GROUP OF FORMULA (III) AND RECOVERING THE COMPOUND OF FORMULA (I) IN THE FORM OF AN ADDITION SALT THEREOF, IN WHICH X STANDS FOR O OR S; R1 SIGNIFIES H, C 1 TO 4 ALKYL OR PHENYL; R2 MEANS C 1 TO 3 ALKYL AND R3 MEANS PHENYL OR PYRIDYL, WITHOUT SUBSTITUTING OR CARRYING EACH ONE, ONE, TWO OR THREE SUBSTITUENTS CHOSEN BETWEEN AN ATOMIC NUMBER OF 9 TO 35, C 1 TO 4 ALKYL AND C 1 TO 4 ALCOXY, OR REPRESENTS ALKYC 1 TO 4 AND ACID ADDITION SALTS OF THE COMPOUNDS. THE REACTION IS CARRIED OUT AT A TEMPERATURE BETWEEN 50 AND 100JC AND IN AN ATMOSPHERE OF AN INERT GAS SUCH AS NITROGEN.

ES524815A 1982-08-09 1983-08-08 PROCEDURE FOR THE PREPARATION OF A (TIO) -ETER OF 2-METHYL-LISERG-8-ILO Granted ES524815A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (en) 1982-08-09 1982-08-09 ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.

Publications (2)

Publication Number Publication Date
ES8502992A1 true ES8502992A1 (en) 1985-02-01
ES524815A0 ES524815A0 (en) 1985-02-01

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524815A Granted ES524815A0 (en) 1982-08-09 1983-08-08 PROCEDURE FOR THE PREPARATION OF A (TIO) -ETER OF 2-METHYL-LISERG-8-ILO

Country Status (23)

Country Link
JP (1) JPS5948480A (en)
AT (1) AT383125B (en)
AU (1) AU563736B2 (en)
BE (1) BE897473A (en)
CA (1) CA1215972A (en)
CH (1) CH649998A5 (en)
DE (1) DE3327705A1 (en)
DK (1) DK361983A (en)
ES (1) ES524815A0 (en)
FI (1) FI73679C (en)
FR (1) FR2531433B1 (en)
GB (1) GB2125041B (en)
GR (1) GR78923B (en)
HU (1) HU187600B (en)
IL (1) IL69450A (en)
IT (1) IT1168961B (en)
MY (1) MY8700166A (en)
NL (1) NL8302776A (en)
NZ (1) NZ205181A (en)
PH (1) PH20385A (en)
PT (1) PT77168B (en)
SE (1) SE8304315L (en)
ZA (1) ZA835850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (en) * 1989-04-21 1990-10-25 Schering Ag 8 (BETA) SUBSTITUTED ERGOLINE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
PT77168B (en) 1986-03-27
AU1767283A (en) 1984-02-16
IL69450A (en) 1986-10-31
FI73679B (en) 1987-07-31
ZA835850B (en) 1985-03-27
GB2125041A (en) 1984-02-29
IT1168961B (en) 1987-05-20
FR2531433B1 (en) 1985-10-18
DK361983A (en) 1984-02-10
AU563736B2 (en) 1987-07-23
FI832789A0 (en) 1983-08-02
FI832789L (en) 1984-02-10
ATA286383A (en) 1986-10-15
DK361983D0 (en) 1983-08-08
HU187600B (en) 1986-01-28
GR78923B (en) 1984-10-02
SE8304315D0 (en) 1983-08-08
MY8700166A (en) 1987-12-31
ES524815A0 (en) 1985-02-01
IT8322490A0 (en) 1983-08-09
IL69450A0 (en) 1983-11-30
JPS5948480A (en) 1984-03-19
DE3327705A1 (en) 1984-02-09
GB8321222D0 (en) 1983-09-07
PT77168A (en) 1983-09-01
AT383125B (en) 1987-05-25
GB2125041B (en) 1986-04-23
FR2531433A1 (en) 1984-02-10
PH20385A (en) 1986-12-08
CA1215972A (en) 1986-12-30
CH649998A5 (en) 1985-06-28
FI73679C (en) 1987-11-09
NZ205181A (en) 1986-07-11
BE897473A (en) 1984-02-06
SE8304315L (en) 1984-02-10
NL8302776A (en) 1984-03-01

Similar Documents

Publication Publication Date Title
ES8507480A1 (en) Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
ES8503669A1 (en) PROCEDURE FOR PREPARING N-IMIDAZOLYLIC DERIVATIVES OF BICYCLE COMPOUNDS.
ES473074A1 (en) Thienothiazine derivatives, their preparation and compositions containing them.
ES8306156A1 (en) 7-(substituted or unsubstituted amino) 3-substituted methyl-3cephem-4-carboxylic acid
ES485274A1 (en) A PROCEDURE FOR THE PREPARATION OF PHENYL-PIPERACINE DERIVATIVES
ES8206491A1 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 2,4-DIAMINOQUINAZOLINE.
ES8404184A1 (en) A PROCEDURE FOR THE PREPARATION OF NEW 2-CARBAMIMIDOIL-1-, CARBADESTIAPEN-2-EN-3-CARBOXYLATED ACID DERIVATIVES.
ES8801618A1 (en) A PROCEDURE FOR PREPARING ARYCYCLOBUTYL ALKYLAMINE DERIVATIVES
ES8504738A1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions.
ES8504653A1 (en) A PROCEDURE FOR PREPARING NEW ETHENO DERIVATIVES
ES8707239A1 (en) Imidazo derivatives, their preparation and medicaments containing these compounds.
ES479991A1 (en) A PROCEDURE FOR THE PREPARATION OF PHTHALAZINES.
ES8502992A1 (en) PROCEDURE FOR THE PREPARATION OF A (TIO) -ETER OF 2-METHYL-LISERG-8-ILO
ES8308326A1 (en) PROCEDURE FOR THE PREPARATION OF AMIDOBENZAMIDES.
ES8506024A1 (en) Fluoromethylthiooxacephalosporins
ES293991A1 (en) A PROCEDURE FOR MANUFACTURING PIRIDINE DERIVATIVES
GB1069797A (en) ª‡-aminoketone derivatives
MX3034E (en) PROCEDURE FOR PREPARING ACID ESTERS OF ALKYL IDEN AMINO OXI ALKYL CARBOXYL
ES8603835A1 (en) Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them.
ES8202818A1 (en) Tetrazolylcoumarin derivatives, process for preparing the same and composition containing the same.
ES8801661A1 (en) A PROCEDURE FOR PREPARING PENEM DERIVATIVES
ES488901A1 (en) PROCEDURE FOR THE PREPARATION OF NEW BENZOIL-2 GLICILANILIDES SUBSTITUTED DERIVATIVES
ES8600297A1 (en) Imidazole derivatives, their preparation and medicaments containing them.
ES8204415A1 (en) Carboximidamide derivatives, a process for preparing them and pharmaceutical preparations containing same.
ES8406431A1 (en) PROCEDURE FOR PREPARING PLEUROMUTILINE DERIVATIVES